Literature DB >> 34723640

Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis.

Javid Moslehi1, Joe-Elie Salem2, John R Power3, Joachim Alexandre4, Arrush Choudhary5, Benay Ozbay6, Salim Hayek7, Aarti Asnani5, Yuichi Tamura8, Mandar Aras9, Jennifer Cautela10, Franck Thuny10, Lauren Gilstrap11, Dimitri Arangalage12, Steven Ewer13, Shi Huang1, Anita Deswal14, Nicolas L Palaskas14, Daniel Finke15,16, Lorenz Lehman15, Stephane Ederhy2.   

Abstract

Entities:  

Keywords:  cardio-oncology; electrophysiology; immunotherapy; myocarditis

Mesh：

Substances：

Year:  2021        PMID： 34723640      PMCID： PMC8567307          DOI： 10.1161/CIRCULATIONAHA.121.055816

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms.

Authors:  Samantha N Champion; James R Stone
Journal:  Mod Pathol       Date:  2019-09-18       Impact factor: 7.842

2.  Fulminant Myocarditis with Combination Immune Checkpoint Blockade.

Authors:  Douglas B Johnson; Justin M Balko; Margaret L Compton; Spyridon Chalkias; Joshua Gorham; Yaomin Xu; Mellissa Hicks; Igor Puzanov; Matthew R Alexander; Tyler L Bloomer; Jason R Becker; David A Slosky; Elizabeth J Phillips; Mark A Pilkinton; Laura Craig-Owens; Nina Kola; Gregory Plautz; Daniel S Reshef; Jonathan S Deutsch; Raquel P Deering; Benjamin A Olenchock; Andrew H Lichtman; Dan M Roden; Christine E Seidman; Igor J Koralnik; Jonathan G Seidman; Robert D Hoffman; Janis M Taube; Luis A Diaz; Robert A Anders; Jeffrey A Sosman; Javid J Moslehi
Journal:  N Engl J Med       Date:  2016-11-03       Impact factor: 91.245

3.  A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention.

Authors:  Spencer C Wei; Wouter C Meijers; Javid J Moslehi; James P Allison; Margaret L Axelrod; Nana-Ama A S Anang; Elles M Screever; Elizabeth C Wescott; Douglas B Johnson; Elizabeth Whitley; Lorenz Lehmann; Pierre-Yves Courand; James J Mancuso; Lauren E Himmel; Benedicte Lebrun-Vignes; Matthew J Wleklinski; Bjorn C Knollmann; Jayashree Srinivasan; Yu Li; Oluwatomisin T Atolagbe; Xiayu Rao; Yang Zhao; Jing Wang; Lauren I R Ehrlich; Padmanee Sharma; Joe-Elie Salem; Justin M Balko
Journal:  Cancer Discov       Date:  2020-11-30       Impact factor: 38.272

4.  Electrocardiographic features of immune checkpoint inhibitor associated myocarditis.

Authors:  Daniel A Zlotoff; Malek Z O Hassan; Amna Zafar; Raza M Alvi; Magid Awadalla; Syed S Mahmood; Lili Zhang; Carol L Chen; Stephane Ederhy; Ana Barac; Dahlia Banerji; Maeve Jones-O'Connor; Sean P Murphy; Merna Armanious; Brian J Forrestal; Michael C Kirchberger; Otavio R Coelho-Filho; Muhammad A Rizvi; Gagan Sahni; Anant Mandawat; Carlo G Tocchetti; Sarah Hartmann; Hannah K Gilman; Eduardo Zatarain-Nicolás; Michael Mahmoudi; Dipti Gupta; Ryan Sullivan; Sarju Ganatra; Eric H Yang; Lucie M Heinzerling; Franck Thuny; Leyre Zubiri; Kerry L Reynolds; Justine V Cohen; Alexander R Lyon; John Groarke; Paaladinesh Thavendiranathan; Anju Nohria; Michael G Fradley; Tomas G Neilan
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

5.  Macrophages Facilitate Electrical Conduction in the Heart.

Authors:  Maarten Hulsmans; Sebastian Clauss; Ling Xiao; Aaron D Aguirre; Kevin R King; Alan Hanley; William J Hucker; Eike M Wülfers; Gunnar Seemann; Gabriel Courties; Yoshiko Iwamoto; Yuan Sun; Andrej J Savol; Hendrik B Sager; Kory J Lavine; Gregory A Fishbein; Diane E Capen; Nicolas Da Silva; Lucile Miquerol; Hiroko Wakimoto; Christine E Seidman; Jonathan G Seidman; Ruslan I Sadreyev; Kamila Naxerova; Richard N Mitchell; Dennis Brown; Peter Libby; Ralph Weissleder; Filip K Swirski; Peter Kohl; Claudio Vinegoni; David J Milan; Patrick T Ellinor; Matthias Nahrendorf
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582
  5 in total
  10 in total

Review 1.  Sex-Specific Cardiovascular Risks of Cancer and Its Therapies.

Authors:  Nicholas S Wilcox; Seth J Rotz; McKay Mullen; Evelyn J Song; Betty Ky Hamilton; Javid Moslehi; Saro H Armenian; Joseph C Wu; June-Wha Rhee; Bonnie Ky
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

2.  Case Report: Acute Myocarditis Due to PD-L1 Inhibitor Durvalumab Monotherapy in a Patient With Lung Squamous Cell Carcinoma.

Authors:  Bo Zhou; Manxiang Li; Tianjun Chen; Jianqing She
Journal:  Front Med (Lausanne)       Date:  2022-06-21

3.  Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.

Authors:  Enrico Ammirati; Emanuele Bizzi; Giacomo Veronese; Matthieu Groh; Caroline M Van de Heyning; Jukka Lehtonen; Marc Pineton de Chambrun; Alberto Cereda; Chiara Picchi; Lucia Trotta; Javid J Moslehi; Antonio Brucato
Journal:  Front Med (Lausanne)       Date:  2022-03-07

4.  Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept.

Authors:  Michelle Rosenzwajg; Joe-Elie Salem; Lee S Nguyen; Marie Bretagne; Jennifer Arrondeau; Noel Zahr; Stephane Ederhy; Baptiste Abbar; Bruno Pinna; Yves Allenbach; Jean-Paul Mira; Javid Moslehi
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 13.751

5.  Immune Checkpoint Inhibitors-Associated Cardiotoxicity.

Authors:  Chenghui Li; Sajjad A Bhatti; Jun Ying
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

Review 6.  Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations.

Authors:  John R Power; Lucas K Keyt; Eric D Adler
Journal:  Expert Rev Cardiovasc Ther       Date:  2022-04-18

Review 7.  Cardiac Magnetic Resonance Imaging in Immune Check-Point Inhibitor Myocarditis: A Systematic Review.

Authors:  Luca Arcari; Giacomo Tini; Giovanni Camastra; Federica Ciolina; Domenico De Santis; Domitilla Russo; Damiano Caruso; Massimiliano Danti; Luca Cacciotti
Journal:  J Imaging       Date:  2022-04-05

8.  Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.

Authors:  Jutta Bergler-Klein; Peter P Rainer; Markus Wallner; Marc-Michael Zaruba; Jakob Dörler; Armin Böhmer; Tamara Buchacher; Maria Frey; Christopher Adlbrecht; Rupert Bartsch; Mariann Gyöngyösi; Ursula-Maria Fürst
Journal:  Wien Klin Wochenschr       Date:  2022-05-04       Impact factor: 2.275

9.  Artificial intelligence applications in cardio-oncology: Leveraging high dimensional cardiovascular data.

Authors:  Haidee Chen; David Ouyang; Tina Baykaner; Faizi Jamal; Paul Cheng; June-Wha Rhee
Journal:  Front Cardiovasc Med       Date:  2022-07-26

10.  Checkpoint Immunotherapy-Induced Myocarditis and Encephalitis Complicated With Complete AV Block: Not All Hope Is Lost.

Authors:  Álvaro Lorente-Ros; Ez-Alddin Rajjoub-Al-Mahdi; Juan M Monteagudo Ruiz; Sonia Rivas García; Rodrigo Ortega Pérez; Covadonga Fernández Golfín; Jesús Álvarez-García; José L Zamorano Gómez
Journal:  JACC Case Rep       Date:  2022-08-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.